Related Experiment Video
Updated: Dec 6, 2025
06:01
Fluorescence Lifetime Macro Imager for Biomedical Applications
Published on: April 7, 2023
973
Machine Learning Methods for Fluorescence Lifetime Imaging (FLIM) Based Label-Free Detection of Microglia
Md Abdul Kader Sagar1,2, Kevin P Cheng1, Jonathan N Ouellette1,2
1Department of Biomedical Engineering, University of Wisconsin-Madison, Madison, WI, United States.
Frontiers in Neuroscience
|October 5, 2020
Summary
Machine learning enhances Fluorescence Lifetime Imaging Microscopy (FLIM) to identify microglia using nicotinamide adenine dinucleotide [NAD(P)H] signals. This label-free method accurately distinguishes microglia from other brain cells, aiding neurodegenerative disease research.
Area of Science:
- Biophotonics and Imaging
- Neuroscience
- Computational Biology
Background:
- Traditional cell analysis methods struggle with specificity and require labels.
- Fluorescence Lifetime Imaging Microscopy (FLIM) detects metabolic signatures via intrinsic NAD(P)H fluorescence.
- Machine learning can improve FLIM's ability to classify cell types.
Purpose of the Study:
- To demonstrate FLIM combined with Artificial Neural Network (ANN) machine learning for label-free cell type characterization.
- To differentiate microglia from other glial cells in the brain using NAD(P)H FLIM.
- To overcome limitations of antibody-based labeling for microglia identification.
Main Methods:
- Utilized FLIM to capture NAD(P)H lifetime variations in cells.
- Applied ANN-based machine learning to classify cell types based on FLIM data.
- Tested the method on mixed glial cell cultures and fixed brain tissue.
Main Results:
- Achieved a True Positive Rate (TPR) > 0.9 for microglia identification in cell culture.
- Reached a TPR of 0.79 for microglia detection in fixed brain tissue.
- Maintained a False Discovery Rate of approximately 30% in both scenarios.
Conclusions:
- ANN-based NAD(P)H FLIM offers a promising label-free approach for microglia identification.
- This method can potentially advance the study of microglia in neurodegenerative diseases.
- The technique avoids extrinsic labels, enabling in vivo and clinical applications.
